Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MAPS

Meaghan thought psychedelic therapy could help her PTSD. Instead it was the start of a nightmare

When Meaghan did psychedelic therapy she was gagged and pinned down by her therapists. With psychedelics touted as a miracle cure, she wants her story known.

ABC News

Michael Pollan's 'How To Change Your Mind' Now On Netflix, Here Are Reactions From Experts

Michael Pollan's 2018 book “How To Change Your Mind: What the science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence” is available on Netflix (NASDAQ: NFLX).

Benzinga

Psychedelic Art Auction: Over $1.5M Raised At Christie's Curated NFT Sale For MAPS

Cartography of the Mind has raised over $1.5 million.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

10 Psychedelics CEOs To Pay Attention To In 2022

By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both private and public.

Benzinga

MDMA trials under review in Canada over alleged abuse of study participants

Health Canada confirms reviews into trials following complaint of ‘alleged investigator misconduct’

The Guardian - US

Mental health's ‘psychedelic renaissance’

Dr Fiona Hutton and Daisy Lutyens make the case for embracing psychedelic-assisted therapy to help with our mental health crisis

Newsroom.co.nz

Psyched: Christie's Launches NFT Collection Supporting Psychedelic Science, Origin's Listing On CSE Gives Retail Investors Access To Private Companies

The world of psychedelics is getting a crossover with another category in the millennial catalog of trendy investments: NFTs.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Credit Suisse Slashed Snap's Price Target By 23.4%, Still Reiterated Outperform - Read Why

Snap Inc (NYSE:SNAP) recently shared its reduced expectations of Q2 FY22 revenue and EBITDA amid the challenging macroeconomic environment. Credit Suisse analyst Stephen Ju maintained an Outperform rating on Snap as it cut the price target from $77 to $59 (278.7% upside). Ju called out Snap's 1) minimal exposure to travel as consumer dollars flow from…

Benzinga

Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say

Patents are the golden eggs of the booming psychedelic space.

Benzinga

Ecstasy Research Trial Completes Enrollment, Moves Closer To Approval To Treat PTSD

The non-profit Multidisciplinary Association for Psychedelics Studies (MAPS) and its subsidiary MAPS Public Benefit Corporation finished the enrollment stage for the second Phase 3 clinical trial on MDMA (MAPP2).

Benzinga

3 SaaS stocks to Scoop Up in May

Continued digital transformation should propel the demand for software-as-a-service (SaaS) solutions across various industries. Therefore, since the macroeconomic and geopolitical issues have led to quality SaaS stocks WM Technology (MAPS), The Sage Group (SGPYY), and The Descartes Systems (DSGX) witnessing a significant decline lately, these stocks could be ideal additions…

StockNews.com

More than half of people with recent mental health issues feel anxious about managing money

Mental Health Awareness Week is highlighting support available for people worried about handling their finances.

Daily Record

57% with recent mental health problems ‘feel anxious about money’

The Money and Pensions Service is urging people to get help as soon as possible to avoid problems spiralling out of control.

The Independent UK

Terrifying Bigfoot creature spotted on Google Maps - plus seven other creepy sights

Google Street View is a great tool to use when checking directions, but there's also an array of weird and worrying scenes lurking in areas across the globe - if you know where to look

Daily Mirror

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

This Weedmaps Analyst Sees These 'Tailwinds' For Cannabis Tech Provider After Q1 Earnings

Cannabis tech provider WM Technology Inc. (NASDAQ: MAPS), more commonly known as Weedmaps,

Benzinga

WM Technology Posts Higher Net Loss, Negative Adjusted EBITDA In Q1

Cannabis tech provider WM Technology Inc. (NASDAQ: MAPS), d.b.a. Weedmaps, announced Wednesday its financial results for the first quarter ended March 31, 2022, revealing revenue growth of 40% year-over-year to $57.5 million.

Benzinga

BREAKING: Cannabis Tech Provider Weedmaps Acquires Enlighten, An Ad And Menu Biz

As reported during its first-quarter 2022 earnings call, WM Technology Inc (NASDAQ: MAPS), d.b.a. Weedmaps, has completed the acquisition of cannabis-focused digital menu and ad company Enlighten.

Benzinga

EXCLUSIVE: Catalysts To Watch For In The Psychedelic Space

Any biotech investor knows how important catalysts are for the companies in the space. One FDA approval or denial can make or break the price of the stock. In the psychedelic space, catalysts could be even more important, as the industry as a whole is still in its infancy.

Get all your
news in one place.

100’s of premium titles.
One news app.

Android Central

How to find eco-friendly routes and EV charging stops in Google Maps

Google lets you prioritize fuel-efficient routes, shows bike and train information for alternatives, helps you find charging stations for your EV, and more. Here's how to save gas (and the environment) and be more eco-friendly when on the go with Google Maps.

StockNews.com

3 Best Small-Cap Software Stocks to Buy in April

The software industry is expected to grow tremendously in the coming months, thanks to accelerating digitalization and technology dependence amid continuing remote lifestyles. Thus, we think it could be wise to invest now in fundamentally solid small-cap software stocks CSG Systems (CSGS), WM Technology (MAPS), and Benefitfocus (BNFT).

Daily Mirror

P&O workers losing their jobs warned of risk that could wipe out pension pots

Hundreds of P&O Ferries workers laid off last month are in danger of switching their retirement funds into less generous alternatives, financial experts are warning

Benzinga

Is The UK Becoming A Global Center For Psychedelic Medicine?

This article by Freddie Earlam was originally published on Microdose and appears here with permission. If the industry-defining research already conducted at UK centers such as Imperial College, King’s college or even Exeter University’s recent Ketamine Research isn’t enough to convince you, then two more crucial factors surely will. Firstly, a new ‘accelerated pathway’ has…

Benzinga

These 3 Psychedelic Stocks Will Benefit When The FDA Green-Lights MDMA (Molly, Ecstasy)

What Happened: According to the Multidisciplinary Association of Psychedelic Studies (MAPS), a non-profit organization, the FDA is close to greenlighting MDMA as a treatment for PTSD. MAPS reported positive results from a phase-3 trial testing the efficacy of MDMA-assisted therapy.

Benzinga

Numinus Administers MDMA To First Volunteer In Clinical Trial Sponsored By MAPS

Numinus Wellness Inc. (OTCQX:NUMIF), announced that clinical trial MAPPUSX has gotten underway with the enrolling and dosing of the first trial volunteer in Canada. MAPPUSX, which stands for "A multi-site open-label extension study of MDMA-assisted psychotherapy for PTSD”, is sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS) and organized by…

Benzinga

Top 5 Most Influential Psychedelic Studies

This article was originally published on Psychedelic Spotlight and appears here with permission. While psychedelic studies now number in the thousands since Western research began in the 1950s, we unpack five of the most important in recent years as psychedelics are on the cusp of becoming mainstream medicines. When it…

1 … 8 9 10 11

People

Stephen King

1,150 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.